ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2251

Kneeling Disability Associated with the Treatment of Osteoarthritis: Analysis of a Copcord Study in Mexico

Alexia Hernández-Cáceres1, Jacqueline Rodríguez-Amado1, Ingris Peláez-Ballestas2, David Vega-Morales3, Mario Garza-Elizondo1, Roberto Negrete-López1, Lorena Pérez-Barbosa1 and Janett Riega-Torres1, 1Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Departamento de Reumatología, Departamento de Reumatología Hospital General de México “Dr. Eduardo Liceaga”, Distrito Federal, Mexico, 3Rheumatology, Hospital Universitario UANL, Monterrey, Mexico

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disability, osteoarthritis and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Osteoarthritis (OA) is the most prevalent rheumatic disease in Mexico. The core treatment, a combination of pharmacological and non-pharmacological modalities, is mainly performed in primary care. 

Objective: To describe which are the most employed therapeutic resources for osteoarthritis and their associated factors in the urban and rural population of Nuevo León.

Methods

Analysis of a cross-sectional study of patients with OA from a COPCORD study database that included the adult population ≥ 18 years of a representative sample of the State of Nuevo León who met the diagnosis of clinical OA and had information about the anatomical location of the disease. All variables in the COPCORD questionnaire were included and performed a descriptive analysis. For the univariate analysis, the population was divided between those who did and those who didn’t receive treatment. For the multivariate analysis, a regression logistic analysis of all the variables with statistical significance was performed.

Results

There were 696 patients with OA with an average age of 58yr (SD 14.1), 484 (69.5%) women and 579 (83.2%) patients were living in urban areas. Five hundred and two patients (85.1%) had pain in the last 7 days, with a mean VAS pain of 6 (IQR 3); 507 (72.8%) patients had a VAS pain ≥4. Functional disability was present in 133 (19%) patients and a mean HAQ of 0.37 (IQR 0.75) was found. The most common places of OA where knee (356, 51.5%), hand (224, 37%) and generalized OA (93, 13%); 259 (37%) patients already knew their diagnosis by the time of the examination. Four hundred and ninety four (71%) patients reported having treatment for OA, being the most frequently prescribed NSAIDS (289, 58.5%), mostly diclofenac (198, 68.5%). Analgesics were used by 100 (20.2%) patients, mostly acetaminophen (73, 77%). There was more utilization of NSAIDS by physicians (231/289, 79.9%) and of analgesics by self-prescribers (35/100, 35%). In the univariate analysis, the variables associated with treatment where age >58yr (OR 1.3, 95% CI 1.0-1.5), female gender (OR 1.17, 95% CI 1.0-1.3), VAS pain ≥ 4 (OR 1.3, 95% CI 1.1-1.4), functional disability (OR 2.6, 95% CI 1.6-4.1), HAQ > 0.375 (OR 1.9, 95% CI 1.5-2.4), and past diagnosis of OA (OR 5.1, 95% CI 3.3-8.0). In a multivariate analysis, VAS pain ≥ 4 (OR 1.9, 95% CI 1.2-2.8), kneeling disability (OR 3.15, 95% CI 1.3-7.4) and previous diagnosis of OA (OR 7.6, 95% CI 4.5-12.9) had statistical significance.

Conclusion

Associated factors with treatment of OA are VAS pain ≥ 4, kneeling disability and previous diagnosis of OA. 


Disclosure:

A. Hernández-Cáceres,
None;

J. Rodríguez-Amado,
None;

I. Peláez-Ballestas,
None;

D. Vega-Morales,
None;

M. Garza-Elizondo,
None;

R. Negrete-López,
None;

L. Pérez-Barbosa,
None;

J. Riega-Torres,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/kneeling-disability-associated-with-the-treatment-of-osteoarthritis-analysis-of-a-copcord-study-in-mexico/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology